 |
PDBsum entry 3uir
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
3uir
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.3.4.21.7
- plasmin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Lys-|-Xaa > Arg-|-Xaa; higher selectivity than trypsin. Converts fibrin into soluble products.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Plos One
8:e54104
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
The structure of human microplasmin in complex with textilinin-1, an aprotinin-like inhibitor from the Australian brown snake.
|
|
E.K.Millers,
L.A.Johnson,
G.W.Birrell,
P.P.Masci,
M.F.Lavin,
J.de Jersey,
L.W.Guddat.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Textilinin-1 is a Kunitz-type serine protease inhibitor from Australian brown
snake venom. Its ability to potently and specifically inhibit human plasmin
(K(i) = 0.44 nM) makes it a potential therapeutic drug as a systemic
anti-bleeding agent. The crystal structures of the human
microplasmin-textilinin-1 and the trypsin-textilinin-1 complexes have been
determined to 2.78 Å and 1.64 Å resolution respectively, and show that
textilinin-1 binds to trypsin in a canonical mode but to microplasmin in an
atypical mode with the catalytic histidine of microplasmin rotated out of the
active site. The space vacated by the histidine side-chain in this complex is
partially occupied by a water molecule. In the structure of microplasminogen the
χ(1) dihedral angle of the side-chain of the catalytic histidine is rotated by
67° from its "active" position in the catalytic triad, as exemplified by its
location when microplasmin is bound to streptokinase. However, when textilinin-1
binds to microplasmin the χ(1) dihedral angle of this amino acid residue
changes by -157° (i.e. in the opposite rotation direction compared to
microplasminogen). The unusual mode of interaction between textilinin-1 and
plasmin explains textilinin-1's selectivity for human plasmin over plasma
kallikrein. This difference can be exploited in future drug design efforts.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|